TY - JOUR
KW - Antidepressants
KW - benzodiazapines
KW - Opioids
KW - Z-drugs
KW - dependency
KW - Gabapentinoids
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Adulthood (18 yrs & older)
KW - Public Health
KW - Treatment Guidelines
KW - gabapentin
KW - Prescription Drugs
KW - Antidepressant Drugs
KW - Opioid analgesics
KW - Benzodiazepines
KW - Prescribing (Drugs)
KW - England
KW - article
KW - 3340:Clinical Psychopharmacology
AU - J. Davies
AU - R. E. Cooper
AU - J. Moncrieff
AU - L. Montagu
AU - T. Rae
AU - M. Parhi
A1 - 
AD - University of Roehampton, Department of Life Sciences, United Kingdom james.davies@stx.oxon.org; University of Greenwich, Faculty of Education, Health and Human Sciences, United Kingdom ; Research & Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, United Kingdom ; All –Party Parliamentary Group for Prescribed Drug Dependence (secretariat), Westminster, United Kingdom ; Roehampton Business School, University of Roehampton, United Kingdom ; Davies, J.,james.davies@stx.oxon.org
BT - Addictive Behaviors
C5 - Financing & Sustainability; Opioids & Substance Use
DO - 10.1016/j.addbeh.2021.107143
JF - Addictive Behaviors
LA - English
M1 - Journal Article
PY - 2022
SN - 0306-4603, 0306-4603
SP - 11
T1 - The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications
T2 - Addictive Behaviors
TI - The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications
U1 - Financing & Sustainability; Opioids & Substance Use
U3 - 10.1016/j.addbeh.2021.107143
VL - 125
VO - 0306-4603, 0306-4603
Y1 - 2022
Y2 - 02
ER -